![]() |
Lung Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Artificial Intelligence for Low-Dose CT Lung Cancer Screening: Comparison of
Utilization Scenarios.
AJR Am J Roentgenol. 2025 Apr 16. doi: 10.2214/AJR.25.32829.
PubMed
Abstract available
Updates on the Version 9 American Joint Committee on Cancer Staging System for
Lung Cancer.
Ann Surg Oncol. 2025 Apr 15. doi: 10.1245/s10434-025-17327.
PubMed
Association of Medicaid Expansion With Timely Treatment and Access to High-Volume
Hospitals in Early-Stage Lung Cancer Patients.
Ann Thorac Surg. 2025 Apr 11:S0003-4975(25)00321.
PubMed
Abstract available
Extended sleeve lobectomy after neoadjuvant immunochemotherapy for centrally
located non-small cell lung cancer.
Ann Thorac Surg. 2025 Apr 9:S0003-4975(25)00298.
PubMed
Abstract available
Role of Therapeutic Bronchoscopy in Malignant Central Airway Obstruction Due to
Small Cell Lung Cancer: Results From the EpiGETIF Registry.
Arch Bronconeumol. 2025 Mar 20:S0300-2896(25)00086.
PubMed
Real-world application of targeted next-generation sequencing for identifying
molecular variants in Asian non-small-cell lung cancer.
BMC Cancer. 2025;25:715.
PubMed
Abstract available
The influence of image selection and segmentation on the extraction of lung
cancer imaging radiomics features using 3D-Slicer software.
BMC Cancer. 2025;25:728.
PubMed
Abstract available
MET tyrosine kinase inhibitors in combination with EGFR tyrosine kinase
inhibitors in NSCLC patients with EGFR mutations and acquired MET alterations: a
systematic review and meta-analysis.
BMC Cancer. 2025;25:732.
PubMed
Abstract available
A study protocol for the CHinA National CancEr screening (CHANCES) trial: a
randomized controlled study to compare the screening strategies for lung cancer
and colorectal cancer.
BMC Cancer. 2025;25:727.
PubMed
Abstract available
Neutrophil-to-lymphocyte ratio-based prognostic score can predict outcomes in
patients with advanced non-small cell lung cancer treated with immunotherapy plus
chemotherapy.
BMC Cancer. 2025;25:697.
PubMed
Abstract available
CMSS1: A RNA binding protein with pivotal roles in non-small cell lung cancer
progression and prognosis.
BMC Cancer. 2025;25:688.
PubMed
Abstract available
EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma.
BMC Cancer. 2025;25:681.
PubMed
Abstract available
Development and validation of a nomogram model of lung metastasis in breast
cancer based on machine learning algorithm and cytokines.
BMC Cancer. 2025;25:692.
PubMed
Abstract available
Risk factors for radiation-induced rib fractures following proton beam therapy
for stage I non-small cell lung cancer: a retrospective study.
BMC Cancer. 2025;25:682.
PubMed
Abstract available
Immune checkpoint inhibitor-related myocarditis in patients with lung cancer.
BMC Cancer. 2025;25:685.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
External validation of plasma glycosaminoglycans as biomarkers to improve lung
cancer risk stratification.
Cancer Epidemiol Biomarkers Prev. 2025.
PubMed
Abstract available
Association of Intratumoral Bacterial Abundance With Lung Cancer Prognosis in
Chiba University Hospital Cohort.
Cancer Sci. 2025 Apr 11. doi: 10.1111/cas.70080.
PubMed
Abstract available
Factors Associated with Disease Progression after Discontinuation of Immune
Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced
Non-Small Cell Lung Cancer.
Clin Cancer Res. 2025 Apr 18:OF1-OF13. doi: 10.1158/1078-0432.CCR-24-2990.
PubMed
Abstract available
Can Longitudinal Biomarkers Guide Treatment Decisions? Time Will Tell.
Clin Cancer Res. 2025;31:1381-1382.
PubMed
Abstract available
Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different
Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC.
Clin Cancer Res. 2025;31:1533-1545.
PubMed
Abstract available
Interplay of GPC3, Hsa-miR-135b-3p, and FTLP3 in lung cancer metastasis.
Clin Exp Metastasis. 2025;42:26.
PubMed
Abstract available
Systematic Review for the Follow-up of Curatively Treated Patients With Lung
Cancer.
Clin Lung Cancer. 2025 Mar 19:S1525-7304(25)00049.
PubMed
Abstract available
Predictors of Up-To-Date Lung Cancer Screening Among Eligible People in the
United States: A Nationally Representative Dataset.
Clin Lung Cancer. 2025 Mar 17:S1525-7304(25)00051.
PubMed
Abstract available
Brief Report: The Effectiveness of Osimertinib in Advanced Nonsmall Cell Lung
Cancer Harboring Various EGFR Exon 19 Mutation Variants.
Clin Lung Cancer. 2025 Mar 21:S1525-7304(25)00054.
PubMed
Genetic Ancestry and Lung Cancer in Latin American Patients: A Crucial Step for
Understanding a Diverse Population.
Clin Lung Cancer. 2025 Mar 13:S1525-7304(25)00050.
PubMed
Abstract available
Machine learning algorithms integrating positron emission tomography/computed
tomography features to predict pathological complete response after neoadjuvant
chemoimmunotherapy in lung cancer.
Eur J Cardiothorac Surg. 2025 Apr 12:ezaf132. doi: 10.1093.
PubMed
Abstract available
Comparative oncological features of centrally- and peripherally-located small
sized radiologically solid-dominant non-small cell lung cancer.
Eur J Cardiothorac Surg. 2025 Apr 12:ezaf072. doi: 10.1093.
PubMed
Abstract available
Risk of second primary lung cancer among cancer survivors stratified by the site
of first primary cancer and the lung cancer screening eligibility status.
Int J Cancer. 2025 Apr 18. doi: 10.1002/ijc.35452.
PubMed
Abstract available
Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck
Squamous Cell Carcinoma - A multicenter retrospective study.
Int J Radiat Oncol Biol Phys. 2025 Jan 4:S0360-3016(24)03771.
PubMed
Abstract available
Resistance is Futile: Stereotactic Body Radiation Therapy for Oligoprogressive
Non-small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys. 2025;122:1-4.
PubMed
Comparison of programmed death ligand-1 expression in preoperative transbronchial
lung biopsy and resected specimens in non-small cell lung cancer.
J Cancer Res Clin Oncol. 2025;151:139.
PubMed
Abstract available
RAF1 promotes anlotinib resistance in non-small cell lung cancer by inhibiting
apoptosis.
J Cancer Res Clin Oncol. 2025;151:138.
PubMed
Abstract available
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With
Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor
Mutations: ACHILLES/TORG1834.
J Clin Oncol. 2025 Apr 16:JCO2402007. doi: 10.1200/JCO-24-02007.
PubMed
Abstract available
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy
Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the
Scandinavian Randomized Phase III NARLAL2 Trial.
J Clin Oncol. 2025 Apr 18:JCO2401386. doi: 10.1200/JCO-24-01386.
PubMed
Abstract available
Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and
Adjuvant Immunotherapy for Resectable Stage III N2 Non-Small Cell Lung Cancer:
Primary Results from SQUAT trial (WJOG 12119L).
J Thorac Oncol. 2025 Apr 9:S1556-0864(25)00656.
PubMed
Abstract available
A cost-effectiveness analysis of amivantamab plus lazertinib versus osimertinib
in the treatment of US and Chinese patients with EGFR-mutated advanced non-small
cell lung cancer.
Lung Cancer. 2025;203:108533.
PubMed
Abstract available
ctDNA can detect minimal residual disease in curative treated non-small cell lung
cancer patients using a tumor agnostic approach.
Lung Cancer. 2025;203:108528.
PubMed
Abstract available
Efficacy and safety of targeted therapy combined with anti-angiogenesis treatment
in brain metastases of non-small cell lung cancer: a systematic review and
meta-analysis.
Lung Cancer. 2025;203:108532.
PubMed
Abstract available
Chemoradiotherapy efficacy in patients with stage III non-small cell lung cancer
(NSCLC): A prognostic clinical and biomarker-based model.
Lung Cancer. 2025;203:108541.
PubMed
Abstract available
Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant
Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer.
Lung Cancer (Auckl). 2025;16:25-37.
PubMed
Abstract available
7?Difluoromethoxyl?5,4'?di?n?octylygenistein targets the STAT3 pathway by
upregulating microRNA?152?3p expression to inhibit self?renewal and tumor growth
in non?small cell lung carcinoma.
Oncol Rep. 2025;53:66.
PubMed
Abstract available
Recurrence prediction using circulating tumor DNA in patients with early-stage
non-small cell lung cancer after treatment with curative intent: A retrospective
validation study.
PLoS Med. 2025;22:e1004574.
PubMed
Abstract available
CT features and histogram analysis of non-contrast images for differentiating
malignant and benign mediastinal lymph nodes in Non-Small Cell Lung Cancer
(NSCLC).
PLoS One. 2025;20:e0321921.
PubMed
Abstract available
Association between advanced lung cancer inflammation index and gallstone
prevalence among U.S. adults: A population-based study.
PLoS One. 2025;20:e0321733.
PubMed
Abstract available
Trop-2 expression in non-small cell lung cancer.
PLoS One. 2025;20:e0321555.
PubMed
Abstract available
Thank you for your interest in scientific medicine.